The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Molecular Targets of the Phytocannabinoids: A Complex Picture
Open accessAbstract
For centuries, hashish and marihuana, both derived from the Indian hemp Cannabis sativa L., have been used for their medicinal, as well as, their psychotropic effects. These effects are associated with the phytocannabinoids which are oxygen containing C21 aromatic hydrocarbons found in Cannabis sativa L. To date, over 120 phytocannabinoids have been isolated from Cannabis. For many years, it was assumed that the beneficial effects of the phytocannabinoids were mediated by the cannabinoid receptors, CB1 and CB2. However, today we know that the picture is much more complex, with the same phytocannabinoid acting at multiple targets. This contribution focuses on the molecular pharmacology of the phytocannabinoids, including Δ9-THC and CBD, from the prospective of the targets at which these important compounds act.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 2×
“Two very striking features are evident in these crystal structures: (1) the extracellular domain of the receptor is completely covered by either the N-terminus [85] or the EC-2 loop [95], precluding ligand access from the EC milieu; (2) portals between TMHs through which ligands can be shuttled have been identified fo…”
BackgroundStructure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“The endogenous ligands for these receptors, sn-2-arachidonoylglycerol (2-AG) (CB1 and CB2) [87, 88] and anandamide (CB1) [89] are lipid-derived agonists that are made on demand from the lipid bilayer and degraded by membrane associated enzymes [90–92], negating the need for vesicle storage.”
BackgroundInternational Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Pertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
Venkatachalam, K., & Montell, C. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142819 · Cited by 1,909
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568 · cited 1×
“At the GPR55 receptor, this non-psychoactive phytocannabinoid acts as an antagonist preventing [35S]GTPγS binding and Rho activation [14, 46, 47].”
BackgroundChemical constituents of marijuana: The complex mixture of natural cannabinoids
ElSohly, M. A., & Slade, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.011 · Cited by 1,094 · cited 1×
“Although its concentration in the plant is quite low, CBND is one of the psychoactive compounds found in the plant’s flowers [73].”
BackgroundCannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039
De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01166.x · Cited by 946
Molecular Basis for Species-Specific Sensitivity to “Hot” Chili Peppers
Jordt, S.-E., & Julius, D. (2002) · Cell · doi:10.1016/s0092-8674(02)00637-2 · Cited by 880
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 820
TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action
Gao, Y., Cao, E., Julius, D., & Cheng, Y. (2016) · Nature · doi:10.1038/nature17964 · Cited by 814
Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 756
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H.-C., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 712
Crystal Structure of a Lipid G Protein–Coupled Receptor
Hanson, M. A., Roth, C. B., Jo, E., Griffith, M. T., Scott, F. L., Reinhart, G., Desale, H., Clemons, B., Cahalan, S. M., Schuerer, S. C., et al. (2012) · Science · doi:10.1126/science.1215904 · Cited by 666
Wu, L.-J., Sweet, T.-B., & Clapham, D. E. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002725 · Cited by 602
Pharmacological Actions of Cannabinoids
Pertwee, R. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_1 · Cited by 597
Transient receptor potential channels as therapeutic targets
Moran, M. M., McAlexander, M. A., Bíró, T., & Szallasi, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3456 · Cited by 550
Pharmacology of Cannabinoid Receptor Ligands
Pertwee, R. G. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401124036 · Cited by 526
McPartland, J. M., Duncan, M., Di Marzo, V., & Pertwee, R. G. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12944 · Cited by 521
Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515 · cited 2×
“For example, the non-psychotropic phytocannabinoid, CBD, is of great interest because of its anti-inflammatory, analgesic, anti-anxiety and anti-tumor properties [6].”
BackgroundCannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors
O'Sullivan, S. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707423 · Cited by 510
Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling
Bracey, M. H., Hanson, M. A., Masuda, K. R., Stevens, R. C., & Cravatt, B. F. (2002) · Science · doi:10.1126/science.1076535 · Cited by 490
Constructing inhibitory synapses
Moss, S. J., & Smart, T. G. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067500 · Cited by 466
Identification of GPR55 as a lysophosphatidylinositol receptor
Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S., & Sugiura, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.078 · Cited by 459
An update on PPAR activation by cannabinoids
O'Sullivan, S. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13497 · Cited by 449
Iannotti, F. A., Hill, C. L., Leo, A., Alhusaini, A., Soubrane, C., Mazzarella, E., Russo, E., Whalley, B. J., Di Marzo, V., & Stephens, G. J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000524 · Cited by 413
Esposito, G., Scuderi, C., Valenza, M., Togna, G. I., Latina, V., De Filippis, D., Cipriano, M., Carratù, M. R., Iuvone, T., & Steardo, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028668 · Cited by 410
Qin, N., Neeper, M. P., Liu, Y., Hutchinson, T. L., Lubin, M. L., & Flores, C. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0504-08.2008 · Cited by 396
Villella, V. R., Esposito, S., Bruscia, E. M., Maiuri, M. C., Raia, V., Kroemer, G., & Maiuri, L. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00001 · Cited by 389
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
Kathmann, M., Flau, K., Redmer, A., Tränkle, C., & Schlicker, E. (2006) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-006-0033-x · Cited by 377
Structure-activity relationships in cannabinoids.
Razdan, R. K. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06863-2 · Cited by 370
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875
Srivastava, A., Yano, J., Hirozane, Y., Kefala, G., Gruswitz, F., Snell, G., Lane, W., Ivetac, A., Aertgeerts, K., Nguyen, J., et al. (2014) · Nature · doi:10.1038/nature13494 · Cited by 340
De Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P. C., Orlando, P., & Di Marzo, V. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134809 · Cited by 336
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo
Whyte, L. S., Ryberg, E., Sims, N. A., Ridge, S. A., Mackie, K., Greasley, P. J., Ross, R. A., & Rogers, M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902743106 · Cited by 330
De Petrocellis, L., Orlando, P., Moriello, A. S., Aviello, G., Stott, C., Izzo, A. A., & Di Marzo, V. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02338.x · Cited by 323
A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation
Dinh, T. P., Freund, T. F., & Piomelli, D. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00150-0 · Cited by 320
Endocannabinoids: synthesis and degradation
Di Marzo, V. (2006) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/112_0505 · Cited by 311
Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay
Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F., Nguyen, D. G., Caldwell, J. S., & Chen, Y. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806516200 · Cited by 311
Ujváry, I., & Hanuš, L. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.0012 · Cited by 298
Huffman, J. W., Liddle, J., Yu, S., Aung, M. M., Abood, M. E., Wiley, J. L., & Martin, B. R. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00219-9 · Cited by 288
Glycine receptors: recent insights into their structural organization and functional diversity
Betz, H., & Laube, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03908.x · Cited by 288
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Xiong, W., Cui, T., Cheng, K., Yang, F., Chen, S.-R., Willenbring, D., Guan, Y., Pan, H.-L., Ren, K., Xu, Y., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120242 · Cited by 288
Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
Kapur, A., Zhao, P., Sharir, H., Bai, Y., Caron, M. G., Barak, L. S., & Abood, M. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050187 · Cited by 274
How Cold is It? TRPM8 and TRPA1 in the Molecular Logic of Cold Sensation
McKemy, D. D. (2005) · Molecular Pain · doi:10.1186/1744-8069-1-16 · Cited by 273
McPartland, J. M., Glass, M., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707399 · Cited by 266
Diana, M. A., & Marty, A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705726 · Cited by 265
Rock, E., Bolognini, D., Limebeer, C., Cascio, M., Anavi‐Goffer, S., Fletcher, P., Mechoulam, R., Pertwee, R., & Parker, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01621.x · Cited by 255
McHugh, D., Page, J., Dunn, E., & Bradshaw, H. B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01497.x · Cited by 250
Nabissi, M., Morelli, M. B., Santoni, M., & Santoni, G. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs328 · Cited by 248
Cascio, M., Gauson, L., Stevenson, L., Ross, R., & Pertwee, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00515.x · Cited by 241
Yano, M., Matsumura, T., Senokuchi, T., Ishii, N., Murata, Y., Taketa, K., Motoshima, H., Taguchi, T., Sonoda, K., Kukidome, D., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000268411.49545.9c · Cited by 235
The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish.
Mechoulam, R., & Gaoni, Y. (1967) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)90646-4 · Cited by 231
Cannabinoid activation of PPARα; a novel neuroprotective mechanism
Sun, Y., Alexander, S. P. H., Garle, M. J., Gibson, C. L., Hewitt, K., Murphy, S. P., Kendall, D. A., & Bennett, A. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707478 · Cited by 229
Constituents of Cannabis Sativa
ElSohly, M. A., & Gul, W. (2014) · Handbook of Cannabis · doi:10.1093/acprof:oso/9780199662685.003.0001 · Cited by 220
Barann, M., Molderings, G., Brüss, M., Bönisch, H., Urban, B. W., & Göthert, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704829 · Cited by 215
A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor
Hurst, D. P., Grossfield, A., Lynch, D. L., Feller, S., Romo, T. D., Gawrisch, K., Pitman, M. C., & Reggio, P. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041590 · Cited by 200
Self-citationMarzo, V., & Petrocellis, L. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980078 · Cited by 197
Inhibitory Glycine Receptors: An Update
Dutertre, S., Becker, C.-M., & Betz, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.408229 · Cited by 193
Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase
Rhee, M.-H., Vogel, Z., Barg, J., Bayewitch, M., Levy, R., Hanuš, L., Breuer, A., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970126f · Cited by 191
The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice
PERTWEE, R. G. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb06900.x · Cited by 188
Hill, T. D. M., Cascio, M., Romano, B., Duncan, M., Pertwee, R. G., Williams, C. M., Whalley, B. J., & Hill, A. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12321 · Cited by 187
Anavi‐Goffer, S., Baillie, G. L., Irving, A. J., Gertsch, J., Greig, I. R., Pertwee, R. G., & Ross, R. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.296020 · Cited by 186
O’Sullivan, S. E., Tarling, E. J., Bennett, A. J., Kendall, D. A., & Randall, M. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.121 · Cited by 183
Thomas, A., Stevenson, L. A., Wease, K. N., Price, M. R., Baillie, G., Ross, R. A., & Pertwee, R. G. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706414 · Cited by 179
Time-dependent vascular actions of cannabidiol in the rat aorta
O'Sullivan, S. E., Sun, Y., Bennett, A. J., Randall, M. D., & Kendall, D. A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.010 · Cited by 177
Pertwee, R. G., Ross, R. A., Craib, S. J., & Thomas, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02624-9 · Cited by 176
Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors
MacLennan, S. J., Reynen, P. H., Kwan, J., & Bonhaus, D. W. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701915 · Cited by 175
Hejazi, N. S., Zhou, C., Öz, M., Sun, H., Ye, J. H., & Zhang, L. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.019174 · Cited by 175
Hind, W. H., England, T. J., & O’Sullivan, S. E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13368 · Cited by 170
Anand, U., Otto, W. R., Sanchez-Herrera, D., Facer, P., Yiangou, Y., Korchev, Y., Birch, R., Benham, C., Bountra, C., Chessell, I. P., et al. (2008) · Pain · doi:10.1016/j.pain.2008.06.007 · Cited by 166 · cited 1×
“TRPV1 colocalizes with CB1 receptors and CB2 receptors in sensory and brain neurons respectively [131, 132].”
BackgroundA Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
Granja, A. G., Carrillo-Salinas, F., Pagani, A., Gómez-Cañas, M., Negri, R., Navarrete, C., Mecha, M., Mestre, L., Fiebich, B. L., Cantarero, I., et al. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9399-3 · Cited by 165
Rosenthaler, S., Pöhn, B., Kolmanz, C., Nguyen, C. H., Krewenka, C., Huber, A., Kranner, B., Rausch, W., & Moldzio, R. (2014) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2014.09.003 · Cited by 165
Price, T. J., Patwardhan, A. M., Akopian, A. N., Hargreaves, K., & Flores, C. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705711 · Cited by 165
Scuderi, C., Steardo, L., & Esposito, G. (2014) · Phytotherapy Research · doi:10.1002/ptr.5095 · Cited by 161
Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia
Xiong, W., Cheng, K., Cui, T., Godlewski, G., Rice, K. C., Xu, Y., & Zhang, L. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.552 · Cited by 161
15-Lipoxygenase Metabolism of 2-Arachidonylglycerol
Kozak, K. R., Gupta, R. A., Moody, J. S., Ji, C., Boeglin, W. E., DuBois, R. N., Brash, A. R., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201084200 · Cited by 160
Ahrens, J., Demir, R., Leuwer, M., de la Roche, J., Krampfl, K., Foadi, N., Karst, M., & Haeseler, G. (2009) · Pharmacology · doi:10.1159/000201556 · Cited by 154
Bolognini, D., Costa, B., Maione, S., Comelli, F., Marini, P., Marzo, V. D., Parolaro, D., Ross, R. A., Gauson, L. A., Cascio, M. G., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00756.x · Cited by 149
Bayewitch, M. L., Rhee, M. H., Avidor‐Reiss, T., Breuer, A., Mechoulam, R., & Vogel, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9902 · Cited by 149
Ford, L., Roelofs, A. J., Anavi‐Goffer, S., Mowat, L., Simpson, D. G., Irving, A. J., Rogers, M. J., Rajnicek, A. M., & Ross, R. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00743.x · Cited by 146
Boychuk, D., Goddard, G., Mauro, G., & Orellana, M. (2015) · Journal of Oral & Facial Pain and Headache · doi:10.11607/ofph.1274 · Cited by 142
Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
Alhamoruni, A., Lee, A. C., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168237 · Cited by 141
Cannabinoids mediate opposing effects on inflammation‐induced intestinal permeability
Alhamoruni, A., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01589.x · Cited by 138
Cannabinoids and PPARα signalling
Sun, Y., Alexander, S. P. H., Kendall, D. A., & Bennett, A. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341095 · Cited by 137
Phillips, R. S., Friend, A. J., Gibson, F., Houghton, E., Gopaul, S., Craig, J. V., & Pizer, B. L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007786.pub3 · Cited by 135
TRP Channel Cannabinoid Receptors in Skin Sensation, Homeostasis, and Inflammation
Caterina, M. J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000919 · Cited by 135
Pertwee, R. G., Thomas, A., Stevenson, L. A., Ross, R. A., Varvel, S. A., Lichtman, A. H., Martin, B. R., & Razdan, R. K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707124 · Cited by 116
Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia
Akopian, A. N., Ruparel, N. B., Jeske, N. A., Patwardhan, A. M., & Hargreaves, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.008 · Cited by 110
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma
Vara‐Ciruelos, D., Morell, C., Rodríguez‐Henche, N., & Díaz‐Laviada, I. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.141 · Cited by 109
Yang, K. S., Galadari, S., Isaev, D. S., Petroianu, G. A., Shippenberg, T. S., & Öz, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162594 · Cited by 108
The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias
Gonca, E., & Darıcı, F. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414532013 · Cited by 106
Allosteric Modulators of the CB 1 Cannabinoid Receptor: A Structural Update Review
Morales, P., Goya, P., Jagerovic, N., & Hernández‐Folgado, L. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.0005 · Cited by 106
Self-citationPicone, R. P., Khanolkar, A. D., Xu, W., Ayotte, L. A., Thakur, G. A., Hurst, D. P., Abood, M. E., Reggio, P. H., Fournier, D. J., & Makriyannis, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014407 · Cited by 104
Self-citationPei, Y., Mercier, R. W., Anday, J. K., Thakur, G. A., Zvonok, A. M., Hurst, D. P., Reggio, P. H., Janero, D. R., & Makriyannis, A. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.011 · Cited by 102
Self-citationPPAR-γ: A nuclear receptor with affinity for cannabinoids
BURSTEIN, S. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.039 · Cited by 85
Shani, A., & Mechoulam, R. (1974) · Tetrahedron · doi:10.1016/s0040-4020(01)97114-5 · Cited by 79
Ambrosio, A. L. B., Dias, S. M. G., Polikarpov, I., Zurier, R. B., BURSTEIN, S. H., & Garratt, R. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702538200 · Cited by 77
Hughes, M. L. R., Liu, B., Halls, M. L., Wagstaff, K. M., Patil, R., Velkov, T., Jans, D. A., Bunnett, N. W., Scanlon, M. J., & Porter, C. J. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.605998 · Cited by 76
Cascio, M. G., Zamberletti, E., Marini, P., Parolaro, D., & Pertwee, R. G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13000 · Cited by 74
Hashish components. Photochemical production of cannabicyclol from cannabichromene
Crombie, L., Ponsford, R. J., Shani, A., Yagnitinsky, B., & Mechoulam, R. (1968) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)76346-5 · Cited by 71
Cannabinoids for treatment of glaucoma
Novack, G. D. (2016) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000242 · Cited by 69
AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor
Bolognini, D., Cascio, M. G., Parolaro, D., & Pertwee, R. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01503.x · Cited by 66
Cannabivarin and Tetrahydrocannabivarin, Two New Constituents of Hashish
Merkus, F. W. H. M. (1971) · Nature · doi:10.1038/232579a0 · Cited by 66
McHugh, D., Roskowski, D., Xie, S., & Bradshaw, H. B. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00162 · Cited by 63
Further Characterization of the Time-Dependent Vascular Effects of Δ9-Tetrahydrocannabinol
O’Sullivan, S. E., Kendall, D. A., & Randall, M. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095828 · Cited by 61
Stability of cannabinoids in dried samples of cannabis dating from around 1896–1905
Harvey, D. J. (1990) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(90)90068-5 · Cited by 54
Hurst, D. P., Schmeisser, M. G., & Reggio, P. H. (2013) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.01.009 · Cited by 43
Self-citationHartsel, S. C., Loh, W., & Robertson, L. (1983) · Planta Medica · doi:10.1055/s-2007-969870 · Cited by 43
Takeda, S., Ikeda, E., Su, S., Harada, M., Okazaki, H., Yoshioka, Y., Nishimura, H., Ishii, H., Kakizoe, K., Taniguchi, A., et al. (2014) · Toxicology · doi:10.1016/j.tox.2014.09.011 · Cited by 40
Cannabinodiol: Conclusive identification and synthesis of a new cannabinoid from Cannabis sativa
Lousberg, R. J. J. C., Bercht, C. A. L., van Ooyen, R., & Spronck, H. J. W. (1977) · Phytochemistry · doi:10.1016/0031-9422(77)80023-x · Cited by 34
Cannabielsoin as a new metabolite of cannabidiol in mammals
Yamamoto, I., GOHDA, H., Narimatsu, S., Watanabe, K., & Yoshimura, H. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90360-e · Cited by 32
Modulation of Glycine Receptor Function by the Synthetic Cannabinoid HU210
Demir, R., Leuwer, M., de la Roche, J., Krampfl, K., Foadi, N., Karst, M., Dengler, R., Haeseler, G., & Ahrens, J. (2009) · Pharmacology · doi:10.1159/000209291 · Cited by 31
Lack of positive allosteric modulation of mutated α1S267I glycine receptors by cannabinoids
Foadi, N., Leuwer, M., Demir, R., Dengler, R., Buchholz, V., de la Roche, J., Karst, M., Haeseler, G., & Ahrens, J. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0506-9 · Cited by 27
Vree, T. B., Breimer, D. D., van Ginneken, C. A. M., & van Rossum, J. M. (1972) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)94980-5 · Cited by 24
ElSohly, M. A., El‐Feraly, F. S., & Turner, C. E. (1977) · PubMed · Cited by 24
Inhibition of 5-HT3 receptors-activated currents by cannabinoids in rat trigeminal ganglion neurons
Shi, B., Yang, R., Wang, X., Liu, H., Zou, L. B., Xiao-qun, H., Wu, J., Zou, A., & Liu, L. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0047-1 · Cited by 15
Ahrens, J., Leuwer, M., Demir, R., Krampfl, K., de la Roche, J., Foadi, N., Karst, M., & Haeseler, G. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0366-8 · Cited by 15
O’Sullivan, S. E. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.73 · Cited by 11
Antibody-Catalyzed Oxidation of Δ9-Tetrahydrocannabinol
Brogan, A. P., Eubanks, L. M., Koob, G. F., Dickerson, T. J., & Janda, K. D. (2007) · Journal of the American Chemical Society · doi:10.1021/ja070022m · Cited by 8
OBATA, Y., & Ishikawa, Y. (1966) · Agricultural and Biological Chemistry · doi:10.1080/00021369.1966.10858669 · Cited by 8
Cited by
Cannabinoid Ligands Targeting TRP Channels
Muller, C., Morales, P., & Reggio, P. H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00487 · Cited by 567
Self-citationCannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 376
A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis
Berman, P., Futoran, K., Lewitus, G. M., Mukha, D., Benami, M., Shlomi, T., & Meiri, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-32651-4 · Cited by 292
Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus
Nuutinen, T. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.076 · Cited by 285
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Metadata
- Authors
- Morales, P., Hurst, D. P., & Reggio, P. H.
- Venue
- Progress in the Chemistry of Organic Natural Products
- Publisher
- Springer International Publishing
- Published
- 2017
- Volume
- 103
- Pages
- 103-131
- ISSN
- 0071-7886 (ISSN-L)
- 2191-7043
- 2192-4309
- OpenAlex
- W2582140652
- Cited by
- 454
- References
- 126
- FWCI
- 71.48
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.